Home > products > custom-nanocomposites
> fluorescent-labeled-nanocomposites
> dops-dopc-chol-dope-n-dbco-20-49-30-1-molar-ratio-based-fluoroliposome-cyanine-7-lipid-dbco
DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome Cyanine 7 lipid-DBCO
1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt):1,2-dioleoyl-sn-glycero-3-phosphocholine:Cholesterol:1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-dibenzocyclooctyl(20:49:30:1molar ratio)-based Fluoroliposome Cyanine 7 lipid-DBCO
Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
---|---|---|---|---|
R-Mcs-239 | 1EA | inquiry | ||
|
Product description
DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome Cyanine 7 lipid-DBCO provides a highly versatile platform for both drug delivery and bioimaging applications.
Utilize near-infrared of Cyanine 7 fluorescent properties for in vivo imaging of cells and tissues, benefiting research in cancer, cardiovascular diseases, and other biomedical fields.Functionalization with DBCO enables conjugation of targeting agents (e.g., antibodies, peptides) for enhanced specificity in drug delivery applications.Combined therapeutic and diagnostic capabilities, enabling simultaneous treatment and imaging to monitor response to therapies.
Appearance | Freeze-dried powder |
---|---|
Solubility | N/A |
DOPS:DOPC:Chol:DOPE-N-DBCO | 20:49:30:1molar ratio |
Cyanine 7 lipid-Excitation/Emission | 750/773nm |
Liposome Size | 100 nm |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 3 weeks |
Stability | 1 year |
Document
Related Product